Sfoglia per AUTORE
NAPOLI R
Collezione AOU San Luigi di Orbassano
Items : 3
Strike early-strike strong lipid-lowering strategy with proprotein convertase subtilisin/kexin type 9 inhibitors in acute coronary syndrome patients: real-world evidence from the AT-TARGET-IT registry. in European journal of preventive cardiology / Eur J Prev Cardiol. 2024 Nov 11;31(15):1806-1816. doi: 10.1093/eurjpc/zwae170.
2024
ASL Torino 3
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara
ASL Torino 3
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara
Merolla A; Iannone FP; Romano A; Dell'Anno R; Vallefuoco G; Passaretti G; Testa C; Cuomo G; Perrone-Filardi P; Paolillo S; Soricelli A; Salvatore M; Prastaro M; Nardi E; Parlati ALM; Buonocore D; Indolfi C; Fontanarosa S; Marzano F; Bilato C; Crisci M; Paloscia L; Brunetti ND; Casu G; De Luca L; Merlini PA; Maloberti A; Quarta R; Polimeni A; et alii...
Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2024 Aug;34(8):1846-1853. doi: 10.1016/j.numecd.2024.03.023. Epub 2024 Ma
2024
AOU Alessandria
ASL VCO
AOU San Luigi di Orbassano
AOU Alessandria
ASL VCO
AOU San Luigi di Orbassano
Rossi MC; Napoli R; Larosa M; Nicolucci A; Candido R;
Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2023 Nov;33(11):2294-2305. doi: 10.1016/j.numecd.2023.07.025. Epub 2023 J
2023
AOU Alessandria
ASL VCO
AOU San Luigi di Orbassano
AOU Alessandria
ASL VCO
AOU San Luigi di Orbassano
Napoli R; Candido R; Larosa M; Nicolucci A; Rossi MC;